Literature DB >> 34185569

Disease-Specific Excess Mortality During the COVID-19 Pandemic: An Analysis of Weekly US Death Data for 2020.

Dongshan Zhu1, Akihiko Ozaki1, Salim Virani1.   

Abstract

Objectives. To examine the disease-specific excess deaths during the COVID-19 pandemic in the United States. Methods. We used weekly death data from the National Center for Health Statistics to analyze the trajectories of excess deaths from specific diseases in the United States during the COVID-19 pandemic, at the national level and in 4 states, from the first to 52nd week of 2020. We used the average weekly number of deaths in the previous 6 years (2014-2019) as baseline. Results. Compared with the same week at baseline, the trajectory of number of excess deaths from cardiovascular disease (CVD) was highly parallel to the trajectory of the number of excess deaths related to COVID-19. The number of excess deaths from diabetes mellitus, influenza and respiratory diseases, and malignant neoplasms remained relatively stable over time. Conclusions. The parallel trajectory of excess mortality from CVD and COVID-19 over time reflects the fact that essential health services for noncommunicable diseases were reduced or disrupted during the COVID-19 pandemic, and the severer the pandemic, the heavier the impact.

Entities:  

Year:  2021        PMID: 34185569     DOI: 10.2105/AJPH.2021.306315

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  5 in total

1.  Risk of Cardiovascular Events After COVID-19.

Authors:  Larisa G Tereshchenko; Adam Bishop; Nora Fisher-Campbell; Jacqueline Levene; Craig C Morris; Hetal Patel; Erynn Beeson; Jessica A Blank; Jg N Bradner; Michelle Coblens; Jacob W Corpron; Jenna M Davison; Kathleen Denny; Mary S Earp; Simeon Florea; Howard Freeman; Olivia Fuson; Florian H Guillot; Kazi T Haq; Morris Kim; Clinton Kolseth; Olivia Krol; Lisa Lin; Liat Litwin; Aneeq Malik; Evan Mitchell; Aman Mohapatra; Cassandra Mullen; Chad D Nix; Ayodele Oyeyemi; Christine Rutlen; Ashley E Tam; Inga Van Buren; Jessica Wallace; Akram Khan
Journal:  Am J Cardiol       Date:  2022-07-15       Impact factor: 3.133

2.  The Indirect Impact of COVID-19 on Major Clinical Outcomes of People With Parkinson's Disease or Parkinsonism: A Cohort Study.

Authors:  Luca Vignatelli; Flavia Baccari; Laura Maria Beatrice Belotti; Corrado Zenesini; Elisa Baldin; Giovanna Calandra-Buonaura; Pietro Cortelli; Carlo Descovich; Giulia Giannini; Maria Guarino; Giuseppe Loddo; Stefania Alessandra Nassetti; Luisa Sambati; Cesa Scaglione; Susanna Trombetti; Roberto D'Alessandro; Francesco Nonino
Journal:  Front Neurol       Date:  2022-05-16       Impact factor: 4.086

3.  Excess all-cause mortality and COVID-19 reported fatality in Iran (April 2013-September 2021): age and sex disaggregated time series analysis.

Authors:  Seyed Amir Ahmad Safavi-Naini; Yeganeh Farsi; Walid Q Alali; Ali Solhpour; Mohamad Amin Pourhoseingholi
Journal:  BMC Res Notes       Date:  2022-04-05

4.  National mortality data for Germany before and throughout the pandemic: There is an excess mortality exceeding COVID-19-attributed fatalities.

Authors:  Sebastian König; Sven Hohenstein; Johannes Leiner; Gerhard Hindricks; Andreas Meier-Hellmann; Ralf Kuhlen; Andreas Bollmann
Journal:  J Infect       Date:  2022-02-26       Impact factor: 38.637

5.  Deaths related to pulmonary embolism and cardiovascular events before and during the 2020 COVID-19 pandemic: An epidemiological analysis of data from an Italian high-risk area.

Authors:  Davide Voci; Ugo Fedeli; Ioannis T Farmakis; Lukas Hobohm; Karsten Keller; Luca Valerio; Elena Schievano; Claudio Barbiellini Amidei; Stavros V Konstantinides; Nils Kucher; Stefano Barco
Journal:  Thromb Res       Date:  2022-02-20       Impact factor: 3.944

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.